HFA Premium Access

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomised placebo-controlled trial.

Congress Presentation

About the speaker

Professor Michel Komajda

Groupe Hospitalier Paris Saint-Joseph, Paris (France)
31 presentations
0 follower

11 more presentations in this session

The which heart failure intervention is most cost-effective in reducing hospital stay trial.

Speaker: Professor S. Stewart (Adelaide, AU)

Thumbnail

Discussion: The which heart failure intervention is most cost-effective in reducing hospital stay trial.

Thumbnail

Global variations in mortality among patients with heart failure.

Speaker: Doctor H. Dokainish (Hamilton, CA)

Thumbnail

Discussion: Global variations in mortality among patients with heart failure.

Thumbnail

Heart failure with mid ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire EF spectrum.

Speaker: Professor L. Lund (Stockholm, SE)

Thumbnail

Access the full session

Late Breaking Trials II: Focus on chronic heart failure

Speakers: Professor M. Komajda, Professor S. Stewart, Doctor H. Dokainish, Professor L. Lund
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk